Vulvovaginitis – A Complete Patient‑Friendly Guide

Overview

Vulvovaginitis is an inflammation of the vulva (the external genitalia) and the vagina. It is a common condition that can affect women of any age, from pre‑pubertal girls to post‑menopausal women. The inflammation may be caused by infection, irritation, hormonal changes, or a combination of factors.

In the United States, up to 10–15 % of women experience at least one episode of vulvovaginitis each year, and recurrent cases are reported in 30–40 % of those affected.¹ The condition is a leading reason for women to seek primary‑care or gynecologic visits, especially in reproductive‑age groups.

Symptoms

Symptoms can range from mild irritation to severe discomfort. Not every woman will have all of the following, but the presence of any persistent symptom warrants evaluation.

• Itching or burning sensation – often described as “crawling” or “stinging” on the vulva or inside the vagina.
• Vaginal discharge – may be thin or thick, white, gray, yellow, green, or frothy; odor can be mild to foul.
• Redness and swelling – the vulvar skin may appear pink, erythematous, or even ulcerated.
• Painful urination (dysuria) – irritation can affect the urethral opening.
• Dyspareunia – pain during sexual intercourse.
• Lower abdominal or pelvic discomfort – especially if the infection spreads to the upper genital tract.
• Spotting or bleeding – mild spotting after intercourse or between periods can occur.
• Fever or chills – usually only with severe bacterial infection (e.g., pelvic inflammatory disease).

Causes and Risk Factors

Vulvovaginitis is not a single disease; it is a symptom complex that can arise from several distinct etiologies.

Infectious Causes

• Bacterial vaginosis (BV) – overgrowth of anaerobic bacteria such as Gardnerella vaginalis.²
• Candidiasis (yeast infection) – most commonly Candida albicans.³
• Trichomoniasis – caused by the protozoan Trichomonas vaginalis.⁴
• Sexually transmitted infections (STIs) – chlamydia, gonorrhea, herpes simplex virus, and Mycoplasma genitalium can all produce vulvovaginal inflammation.

Irritant or Allergic Causes

• Harsh soaps, scented hygiene products, douches, or bubble baths.
• Condoms or lubricants containing spermicides, latex, or fragrance.
• Clothing that traps moisture (tight underwear, synthetic fabrics).
• Dermatologic conditions such as eczema, lichen sclerosus, or psoriasis.

Hormonal and Physiologic Factors

• Estrogen deficiency – post‑menopausal atrophy makes the mucosa more fragile.
• Pregnancy – hormonal shifts and increased glycogen can predispose to yeast overgrowth.
• Menstrual cycle – changes in pH and moisture during menses can trigger symptoms.

Other Risk Factors

• Antibiotic use (disrupts normal flora).
• Diabetes or uncontrolled blood glucose (promotes yeast growth).
• Immunosuppression (HIV, chemotherapy).
• Sexual activity with a new or multiple partners.
• Poor genital hygiene (e.g., wiping front to back).

Diagnosis

Accurate diagnosis hinges on a thorough history, physical examination, and targeted laboratory testing.

History & Physical Exam

• Duration, frequency, and pattern of symptoms.
• Recent antibiotic or hormonal medication use.
• Sexual history, contraceptive methods, and hygiene practices.
• Visual inspection of the vulva and vaginal walls for erythema, discharge, lesions, or ulceration.

Laboratory Tests

• Microscopic (wet mount) examination – looks for clue cells (BV), hyphae or budding yeast (candidiasis), and motile trichomonads.
• Amsel’s criteria for BV (pH > 4.5, clue cells, thin gray discharge, fishy odor).
• Nugent score – Gram‑stain scoring system for BV.
• Culture or PCR – for Candida species, Trichomonas, and STIs (e.g., Chlamydia trachomatis, Neisseria gonorrhoeae).
• pH testing – vaginal pH > 4.5 suggests bacterial vaginosis or trichomoniasis; pH < 4.5 is typical for candidiasis.
• In recurrent or atypical cases, a biopsy may be performed to rule out dermatoses or malignancy.

Treatment Options

Treatment is tailored to the underlying cause and severity of symptoms.

Infectious Etiologies

• Bacterial Vaginosis
  • Metronidazole 500 mg orally twice daily for 7 days or a single 2 g dose.
  • Clindamycin cream 2 % intravaginally for 7 days (alternative for metronidazole intolerance).
• Candidiasis
  • Fluconazole 150 mg PO single dose (most common).
  • Topical azoles (clotrimazole, miconazole) 1 % cream or suppository for 7 days.
  • For recurrent infection (≥4 episodes/year): maintenance fluconazole 150 mg weekly for 6 months.
• Trichomoniasis
  • Metronidazole 2 g PO single dose or 500 mg BID for 7 days.
  • All sexual partners should be treated simultaneously.
• STI‑related vulvovaginitis
  • Appropriate antibiotics (e.g., doxycycline for chlamydia, ceftriaxone + azithromycin for gonorrhea).
  • Antiviral therapy (acyclovir) for herpes simplex lesions.

Irritant/Allergic Causes

• Discontinue offending products (perfumed soaps, spermicides, scented wipes).
• Apply barrier creams (zinc oxide or petroleum jelly) to protect the skin.
• For allergic contact dermatitis, a short course of low‑potency topical corticosteroids (hydrocortisone 1 % cream) may be prescribed.

Hormonal & Atrophic Changes

• Topical estrogen therapy (estradiol cream or vaginal tablet) for post‑menopausal women.
• Non‑hormonal moisturizers and lubricants for daily comfort.

Lifestyle & Supportive Measures

• Wear breathable cotton underwear; avoid tight synthetic fabrics.
• Practice gentle cleansing with warm water only; avoid douching.
• Maintain good glycemic control if diabetic.
• Limit sugar and refined carbohydrates during active yeast infection.

Living with Vulvovaginitis

Even after successful treatment, many women experience recurrent episodes. The following strategies can help minimize flare‑ups and improve quality of life.

Daily Hygiene

• Wash the external genitalia with lukewarm water; use mild, unscented soap only if needed.
• After toileting, always wipe front to back.
• Change out of wet clothing (swimsuits, workout gear) promptly.

Sexual Health

• Use water‑based, fragrance‑free lubricants to reduce friction.
• Consider condom use if a partner has an STI or if you have recurrent bacterial vaginosis.
• Discuss any recurrent infections with your partner; simultaneous treatment may be required.

Nutrition & Lifestyle

• Probiotic‑rich foods (yogurt, kefir, fermented vegetables) may help restore normal vaginal flora, though evidence is modest.⁵
• Stay hydrated; adequate fluid intake supports mucosal health.
• Manage stress through relaxation techniques—stress can affect immune function and hormone balance.

Follow‑up Care

• Schedule a follow‑up visit 1–2 weeks after treatment to confirm resolution.
• If symptoms recur within a month, return promptly for re‑evaluation.
• Keep a symptom diary (date, discharge characteristics, triggers) to discuss with your clinician.

Prevention

Preventive measures focus on maintaining a balanced vaginal ecosystem and reducing irritant exposure.

• Limit use of scented feminine products and avoid douching.
• Choose breathable underwear and change menstrual products regularly (every 4–6 hours).
• Complete the full course of any prescribed antibiotics; consider probiotic supplementation if you have frequent BV after antibiotics.
• Control blood glucose if you have diabetes.
• Practice safe sex—use condoms and get regular STI screenings.
• For post‑menopausal women, discuss low‑dose vaginal estrogen with your provider if atrophic symptoms are present.

Complications

If left untreated, vulvovaginitis can lead to more serious health issues.

• Pelvic Inflammatory Disease (PID) – Ascending infection from the vagina to the uterus, fallopian tubes, and ovaries, potentially causing infertility.
• Urinary Tract Infections (UTIs) – Irritation of the urethra can predispose to bacterial colonization.
• Chronic Pain Syndromes – Persistent inflammation may evolve into vulvodynia or chronic pelvic pain.
• Preterm labor – In pregnant women, certain infections (e.g., bacterial vaginosis) are linked with higher rates of preterm birth.⁶
• Psychosocial impact – Ongoing discomfort can affect sexual intimacy, self‑esteem, and mental health.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. “Vaginitis.” CDC. Accessed Dec 2025.
2. Mayo Clinic. “Bacterial Vaginosis.” Mayo Clinic. 2024.
3. World Health Organization. “Vulvovaginal Candidiasis.” WHO Fact Sheet. 2023.
4. CDC. “Trichomoniasis – CDC Fact Sheet.” CDC. 2024.
5. Reid G, et al. Probiotics for preventing bacterial vaginosis recurrence: a systematic review. *J Clin Gynecol Obstet*. 2022;31(2):123‑130.
6. American College of Obstetricians and Gynecologists. “Bacterial Vaginosis and Pregnancy.” *ACOG Committee Opinion No. 822*, 2023.